Global Mesenchymal Stem Cells Supply, Demand and Key Producers, 2026-2032
The global Mesenchymal Stem Cells market size is expected to reach $ 2827 million by 2032, rising at a market growth of 10.4% CAGR during the forecast period (2026-2032).
Mesenchymal Stem Cells (MSCs) are multipotent stem cells derived from various tissues such as bone marrow, umbilical cord, adipose tissue, and placenta. They possess strong self-renewal and multilineage differentiation capabilities, enabling them to differentiate into osteoblasts, chondrocytes, adipocytes, and other mesenchymal-origin cells. MSCs are characterized by low immunogenicity, immunomodulatory effects, and robust cytokine secretion, making them a key focus in regenerative medicine, immune therapy, and anti-inflammatory treatment. With advancements in cell culture techniques, serum-free media, and GMP-compliant manufacturing, MSCs are transitioning from preclinical research to clinical applications, finding broad use in orthopedic disorders, cardiovascular diseases, autoimmune conditions, oncology, and tissue engineering. The MSC industry spans upstream cell sourcing, large-scale expansion, cryopreservation, logistics, and therapeutic product development, positioning MSCs as a cornerstone of the global cell and gene therapy (CGT) market and a critical driver of precision medicine, drawing strong attention from investors and regulatory authorities worldwide.
The mesenchymal stem cell (MSC) industry is entering a phase of accelerated growth, driven by the global boom in cell and gene therapy R&D, rising healthcare needs of aging populations, and supportive regenerative medicine policies. According to public annual reports, the number of ongoing MSC clinical trials continues to grow, with over 300 trials registered in the U.S. and China in 2024 alone, covering neurological, metabolic, and autoimmune disorders. Governments are investing heavily in innovation, supporting GMP-compliant manufacturing facilities and quality standardization, reducing technical barriers. Frequent collaborations between multinational pharmaceutical companies and regional CDMOs are facilitating industrial-scale production and rapid market penetration. With increasing investments from Asia and the Middle East, MSCs are poised to become a strategic focus in global precision and personalized medicine development.
Despite rapid growth, the MSC industry faces challenges such as complex cell sourcing, difficulties in large-scale manufacturing, inconsistent clinical protocols, and varying regulatory requirements across regions. Many companies lack mature experience in process optimization and batch consistency, resulting in high costs and extended commercialization timelines. Intellectual property barriers, cross-border clinical certifications, and global regulatory complexities further increase entry thresholds, particularly for small and mid-sized players. Market uncertainties, including fluctuations in capital markets and healthcare reimbursement policies, also pose risks. Balancing strict quality standards, cost efficiency, and accessible pricing will be critical for shaping the competitive landscape.
Demand is rapidly shifting from basic research to commercial clinical applications. The growth of immunotherapy, tissue engineering, and personalized medicine is expanding MSC use cases, including cardiovascular repair, cartilage regeneration, autoimmune disease management, anti-aging therapies, and medical aesthetics. Emerging integration with mRNA technology and gene editing is creating vast opportunities for premium, customized MSC products. Companies and research institutions are accelerating automation and digital process control to enhance product consistency and reduce costs. The convergence of aging demographics, chronic disease prevalence, and supportive policy frameworks positions MSCs as a central growth engine in the global cell therapy market over the next five years.
This report studies the global Mesenchymal Stem Cells demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Mesenchymal Stem Cells, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Mesenchymal Stem Cells that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Mesenchymal Stem Cells total market, 2021-2032, (USD Million)
Global Mesenchymal Stem Cells total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Mesenchymal Stem Cells total market, key domestic companies, and share, (USD Million)
Global Mesenchymal Stem Cells revenue by player, revenue and market share 2021-2026, (USD Million)
Global Mesenchymal Stem Cells total market by Type, CAGR, 2021-2032, (USD Million)
Global Mesenchymal Stem Cells total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Mesenchymal Stem Cells market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CellResearch, StemCord, Cytopeutics, CryoCord, Cell Malaysia, Bangkok Stem Cell, Vinmec Stem Cell Institute, ProSTEM, Cryoviva, StemCells21, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Mesenchymal Stem Cells market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Mesenchymal Stem Cells Market, By Region:
1. How big is the global Mesenchymal Stem Cells market?
2. What is the demand of the global Mesenchymal Stem Cells market?
3. What is the year over year growth of the global Mesenchymal Stem Cells market?
4. What is the total value of the global Mesenchymal Stem Cells market?
5. Who are the Major Players in the global Mesenchymal Stem Cells market?
6. What are the growth factors driving the market demand?
Mesenchymal Stem Cells (MSCs) are multipotent stem cells derived from various tissues such as bone marrow, umbilical cord, adipose tissue, and placenta. They possess strong self-renewal and multilineage differentiation capabilities, enabling them to differentiate into osteoblasts, chondrocytes, adipocytes, and other mesenchymal-origin cells. MSCs are characterized by low immunogenicity, immunomodulatory effects, and robust cytokine secretion, making them a key focus in regenerative medicine, immune therapy, and anti-inflammatory treatment. With advancements in cell culture techniques, serum-free media, and GMP-compliant manufacturing, MSCs are transitioning from preclinical research to clinical applications, finding broad use in orthopedic disorders, cardiovascular diseases, autoimmune conditions, oncology, and tissue engineering. The MSC industry spans upstream cell sourcing, large-scale expansion, cryopreservation, logistics, and therapeutic product development, positioning MSCs as a cornerstone of the global cell and gene therapy (CGT) market and a critical driver of precision medicine, drawing strong attention from investors and regulatory authorities worldwide.
The mesenchymal stem cell (MSC) industry is entering a phase of accelerated growth, driven by the global boom in cell and gene therapy R&D, rising healthcare needs of aging populations, and supportive regenerative medicine policies. According to public annual reports, the number of ongoing MSC clinical trials continues to grow, with over 300 trials registered in the U.S. and China in 2024 alone, covering neurological, metabolic, and autoimmune disorders. Governments are investing heavily in innovation, supporting GMP-compliant manufacturing facilities and quality standardization, reducing technical barriers. Frequent collaborations between multinational pharmaceutical companies and regional CDMOs are facilitating industrial-scale production and rapid market penetration. With increasing investments from Asia and the Middle East, MSCs are poised to become a strategic focus in global precision and personalized medicine development.
Despite rapid growth, the MSC industry faces challenges such as complex cell sourcing, difficulties in large-scale manufacturing, inconsistent clinical protocols, and varying regulatory requirements across regions. Many companies lack mature experience in process optimization and batch consistency, resulting in high costs and extended commercialization timelines. Intellectual property barriers, cross-border clinical certifications, and global regulatory complexities further increase entry thresholds, particularly for small and mid-sized players. Market uncertainties, including fluctuations in capital markets and healthcare reimbursement policies, also pose risks. Balancing strict quality standards, cost efficiency, and accessible pricing will be critical for shaping the competitive landscape.
Demand is rapidly shifting from basic research to commercial clinical applications. The growth of immunotherapy, tissue engineering, and personalized medicine is expanding MSC use cases, including cardiovascular repair, cartilage regeneration, autoimmune disease management, anti-aging therapies, and medical aesthetics. Emerging integration with mRNA technology and gene editing is creating vast opportunities for premium, customized MSC products. Companies and research institutions are accelerating automation and digital process control to enhance product consistency and reduce costs. The convergence of aging demographics, chronic disease prevalence, and supportive policy frameworks positions MSCs as a central growth engine in the global cell therapy market over the next five years.
This report studies the global Mesenchymal Stem Cells demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Mesenchymal Stem Cells, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Mesenchymal Stem Cells that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Mesenchymal Stem Cells total market, 2021-2032, (USD Million)
Global Mesenchymal Stem Cells total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Mesenchymal Stem Cells total market, key domestic companies, and share, (USD Million)
Global Mesenchymal Stem Cells revenue by player, revenue and market share 2021-2026, (USD Million)
Global Mesenchymal Stem Cells total market by Type, CAGR, 2021-2032, (USD Million)
Global Mesenchymal Stem Cells total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Mesenchymal Stem Cells market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CellResearch, StemCord, Cytopeutics, CryoCord, Cell Malaysia, Bangkok Stem Cell, Vinmec Stem Cell Institute, ProSTEM, Cryoviva, StemCells21, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Mesenchymal Stem Cells market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Mesenchymal Stem Cells Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Umbilical Cord Derived MSC
- Bone Marrow Derived MSC
- Placenta Derived MSC
- Other
- Research
- Disease Treatment
- Beauty and Anti-aging
- Storage
- CellResearch
- StemCord
- Cytopeutics
- CryoCord
- Cell Malaysia
- Bangkok Stem Cell
- Vinmec Stem Cell Institute
- ProSTEM
- Cryoviva
- StemCells21
- Lonza
- Thermo Fisher Scientific
- PromoCell
- Stemcell Technologies
- Bio-Techne
- ATCC
- Merck
1. How big is the global Mesenchymal Stem Cells market?
2. What is the demand of the global Mesenchymal Stem Cells market?
3. What is the year over year growth of the global Mesenchymal Stem Cells market?
4. What is the total value of the global Mesenchymal Stem Cells market?
5. Who are the Major Players in the global Mesenchymal Stem Cells market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Mesenchymal Stem Cells Introduction
1.2 World Mesenchymal Stem Cells Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Mesenchymal Stem Cells Total Market by Region (by Headquarter Location)
1.3.1 World Mesenchymal Stem Cells Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Mesenchymal Stem Cells Revenue (2021-2032)
1.3.3 China Based Company Mesenchymal Stem Cells Revenue (2021-2032)
1.3.4 Europe Based Company Mesenchymal Stem Cells Revenue (2021-2032)
1.3.5 Japan Based Company Mesenchymal Stem Cells Revenue (2021-2032)
1.3.6 South Korea Based Company Mesenchymal Stem Cells Revenue (2021-2032)
1.3.7 ASEAN Based Company Mesenchymal Stem Cells Revenue (2021-2032)
1.3.8 India Based Company Mesenchymal Stem Cells Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Mesenchymal Stem Cells Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Mesenchymal Stem Cells Consumption Value (2021-2032)
2.2 World Mesenchymal Stem Cells Consumption Value by Region
2.2.1 World Mesenchymal Stem Cells Consumption Value by Region (2021-2026)
2.2.2 World Mesenchymal Stem Cells Consumption Value Forecast by Region (2027-2032)
2.3 United States Mesenchymal Stem Cells Consumption Value (2021-2032)
2.4 China Mesenchymal Stem Cells Consumption Value (2021-2032)
2.5 Europe Mesenchymal Stem Cells Consumption Value (2021-2032)
2.6 Japan Mesenchymal Stem Cells Consumption Value (2021-2032)
2.7 South Korea Mesenchymal Stem Cells Consumption Value (2021-2032)
2.8 ASEAN Mesenchymal Stem Cells Consumption Value (2021-2032)
2.9 India Mesenchymal Stem Cells Consumption Value (2021-2032)
3 WORLD MESENCHYMAL STEM CELLS COMPANIES COMPETITIVE ANALYSIS
3.1 World Mesenchymal Stem Cells Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Mesenchymal Stem Cells Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Mesenchymal Stem Cells in 2025
3.2.3 Global Concentration Ratios (CR8) for Mesenchymal Stem Cells in 2025
3.3 Mesenchymal Stem Cells Company Evaluation Quadrant
3.4 Mesenchymal Stem Cells Market: Overall Company Footprint Analysis
3.4.1 Mesenchymal Stem Cells Market: Region Footprint
3.4.2 Mesenchymal Stem Cells Market: Company Product Type Footprint
3.4.3 Mesenchymal Stem Cells Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Mesenchymal Stem Cells Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Mesenchymal Stem Cells Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Mesenchymal Stem Cells Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Mesenchymal Stem Cells Consumption Value Comparison
4.2.1 United States VS China: Mesenchymal Stem Cells Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Mesenchymal Stem Cells Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Mesenchymal Stem Cells Companies and Market Share, 2021-2026
4.3.1 United States Based Mesenchymal Stem Cells Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Mesenchymal Stem Cells Revenue, (2021-2026)
4.4 China Based Companies Mesenchymal Stem Cells Revenue and Market Share, 2021-2026
4.4.1 China Based Mesenchymal Stem Cells Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Mesenchymal Stem Cells Revenue, (2021-2026)
4.5 Rest of World Based Mesenchymal Stem Cells Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Mesenchymal Stem Cells Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Mesenchymal Stem Cells Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Mesenchymal Stem Cells Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Umbilical Cord Derived MSC
5.2.2 Bone Marrow Derived MSC
5.2.3 Placenta Derived MSC
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Mesenchymal Stem Cells Market Size by Type (2021-2026)
5.3.2 World Mesenchymal Stem Cells Market Size by Type (2027-2032)
5.3.3 World Mesenchymal Stem Cells Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Mesenchymal Stem Cells Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Research
6.2.2 Disease Treatment
6.2.3 Beauty and Anti-aging
6.2.4 Storage
6.3 Market Segment by Application
6.3.1 World Mesenchymal Stem Cells Market Size by Application (2021-2026)
6.3.2 World Mesenchymal Stem Cells Market Size by Application (2027-2032)
6.3.3 World Mesenchymal Stem Cells Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 CellResearch
7.1.1 CellResearch Details
7.1.2 CellResearch Major Business
7.1.3 CellResearch Mesenchymal Stem Cells Product and Services
7.1.4 CellResearch Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 CellResearch Recent Developments/Updates
7.1.6 CellResearch Competitive Strengths & Weaknesses
7.2 StemCord
7.2.1 StemCord Details
7.2.2 StemCord Major Business
7.2.3 StemCord Mesenchymal Stem Cells Product and Services
7.2.4 StemCord Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 StemCord Recent Developments/Updates
7.2.6 StemCord Competitive Strengths & Weaknesses
7.3 Cytopeutics
7.3.1 Cytopeutics Details
7.3.2 Cytopeutics Major Business
7.3.3 Cytopeutics Mesenchymal Stem Cells Product and Services
7.3.4 Cytopeutics Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Cytopeutics Recent Developments/Updates
7.3.6 Cytopeutics Competitive Strengths & Weaknesses
7.4 CryoCord
7.4.1 CryoCord Details
7.4.2 CryoCord Major Business
7.4.3 CryoCord Mesenchymal Stem Cells Product and Services
7.4.4 CryoCord Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 CryoCord Recent Developments/Updates
7.4.6 CryoCord Competitive Strengths & Weaknesses
7.5 Cell Malaysia
7.5.1 Cell Malaysia Details
7.5.2 Cell Malaysia Major Business
7.5.3 Cell Malaysia Mesenchymal Stem Cells Product and Services
7.5.4 Cell Malaysia Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Cell Malaysia Recent Developments/Updates
7.5.6 Cell Malaysia Competitive Strengths & Weaknesses
7.6 Bangkok Stem Cell
7.6.1 Bangkok Stem Cell Details
7.6.2 Bangkok Stem Cell Major Business
7.6.3 Bangkok Stem Cell Mesenchymal Stem Cells Product and Services
7.6.4 Bangkok Stem Cell Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Bangkok Stem Cell Recent Developments/Updates
7.6.6 Bangkok Stem Cell Competitive Strengths & Weaknesses
7.7 Vinmec Stem Cell Institute
7.7.1 Vinmec Stem Cell Institute Details
7.7.2 Vinmec Stem Cell Institute Major Business
7.7.3 Vinmec Stem Cell Institute Mesenchymal Stem Cells Product and Services
7.7.4 Vinmec Stem Cell Institute Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Vinmec Stem Cell Institute Recent Developments/Updates
7.7.6 Vinmec Stem Cell Institute Competitive Strengths & Weaknesses
7.8 ProSTEM
7.8.1 ProSTEM Details
7.8.2 ProSTEM Major Business
7.8.3 ProSTEM Mesenchymal Stem Cells Product and Services
7.8.4 ProSTEM Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 ProSTEM Recent Developments/Updates
7.8.6 ProSTEM Competitive Strengths & Weaknesses
7.9 Cryoviva
7.9.1 Cryoviva Details
7.9.2 Cryoviva Major Business
7.9.3 Cryoviva Mesenchymal Stem Cells Product and Services
7.9.4 Cryoviva Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Cryoviva Recent Developments/Updates
7.9.6 Cryoviva Competitive Strengths & Weaknesses
7.10 StemCells21
7.10.1 StemCells21 Details
7.10.2 StemCells21 Major Business
7.10.3 StemCells21 Mesenchymal Stem Cells Product and Services
7.10.4 StemCells21 Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 StemCells21 Recent Developments/Updates
7.10.6 StemCells21 Competitive Strengths & Weaknesses
7.11 Lonza
7.11.1 Lonza Details
7.11.2 Lonza Major Business
7.11.3 Lonza Mesenchymal Stem Cells Product and Services
7.11.4 Lonza Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Lonza Recent Developments/Updates
7.11.6 Lonza Competitive Strengths & Weaknesses
7.12 Thermo Fisher Scientific
7.12.1 Thermo Fisher Scientific Details
7.12.2 Thermo Fisher Scientific Major Business
7.12.3 Thermo Fisher Scientific Mesenchymal Stem Cells Product and Services
7.12.4 Thermo Fisher Scientific Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 Thermo Fisher Scientific Recent Developments/Updates
7.12.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.13 PromoCell
7.13.1 PromoCell Details
7.13.2 PromoCell Major Business
7.13.3 PromoCell Mesenchymal Stem Cells Product and Services
7.13.4 PromoCell Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 PromoCell Recent Developments/Updates
7.13.6 PromoCell Competitive Strengths & Weaknesses
7.14 Stemcell Technologies
7.14.1 Stemcell Technologies Details
7.14.2 Stemcell Technologies Major Business
7.14.3 Stemcell Technologies Mesenchymal Stem Cells Product and Services
7.14.4 Stemcell Technologies Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 Stemcell Technologies Recent Developments/Updates
7.14.6 Stemcell Technologies Competitive Strengths & Weaknesses
7.15 Bio-Techne
7.15.1 Bio-Techne Details
7.15.2 Bio-Techne Major Business
7.15.3 Bio-Techne Mesenchymal Stem Cells Product and Services
7.15.4 Bio-Techne Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.15.5 Bio-Techne Recent Developments/Updates
7.15.6 Bio-Techne Competitive Strengths & Weaknesses
7.16 ATCC
7.16.1 ATCC Details
7.16.2 ATCC Major Business
7.16.3 ATCC Mesenchymal Stem Cells Product and Services
7.16.4 ATCC Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.16.5 ATCC Recent Developments/Updates
7.16.6 ATCC Competitive Strengths & Weaknesses
7.17 Merck
7.17.1 Merck Details
7.17.2 Merck Major Business
7.17.3 Merck Mesenchymal Stem Cells Product and Services
7.17.4 Merck Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.17.5 Merck Recent Developments/Updates
7.17.6 Merck Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Mesenchymal Stem Cells Industry Chain
8.2 Mesenchymal Stem Cells Upstream Analysis
8.3 Mesenchymal Stem Cells Midstream Analysis
8.4 Mesenchymal Stem Cells Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Mesenchymal Stem Cells Introduction
1.2 World Mesenchymal Stem Cells Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Mesenchymal Stem Cells Total Market by Region (by Headquarter Location)
1.3.1 World Mesenchymal Stem Cells Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Mesenchymal Stem Cells Revenue (2021-2032)
1.3.3 China Based Company Mesenchymal Stem Cells Revenue (2021-2032)
1.3.4 Europe Based Company Mesenchymal Stem Cells Revenue (2021-2032)
1.3.5 Japan Based Company Mesenchymal Stem Cells Revenue (2021-2032)
1.3.6 South Korea Based Company Mesenchymal Stem Cells Revenue (2021-2032)
1.3.7 ASEAN Based Company Mesenchymal Stem Cells Revenue (2021-2032)
1.3.8 India Based Company Mesenchymal Stem Cells Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Mesenchymal Stem Cells Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Mesenchymal Stem Cells Consumption Value (2021-2032)
2.2 World Mesenchymal Stem Cells Consumption Value by Region
2.2.1 World Mesenchymal Stem Cells Consumption Value by Region (2021-2026)
2.2.2 World Mesenchymal Stem Cells Consumption Value Forecast by Region (2027-2032)
2.3 United States Mesenchymal Stem Cells Consumption Value (2021-2032)
2.4 China Mesenchymal Stem Cells Consumption Value (2021-2032)
2.5 Europe Mesenchymal Stem Cells Consumption Value (2021-2032)
2.6 Japan Mesenchymal Stem Cells Consumption Value (2021-2032)
2.7 South Korea Mesenchymal Stem Cells Consumption Value (2021-2032)
2.8 ASEAN Mesenchymal Stem Cells Consumption Value (2021-2032)
2.9 India Mesenchymal Stem Cells Consumption Value (2021-2032)
3 WORLD MESENCHYMAL STEM CELLS COMPANIES COMPETITIVE ANALYSIS
3.1 World Mesenchymal Stem Cells Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Mesenchymal Stem Cells Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Mesenchymal Stem Cells in 2025
3.2.3 Global Concentration Ratios (CR8) for Mesenchymal Stem Cells in 2025
3.3 Mesenchymal Stem Cells Company Evaluation Quadrant
3.4 Mesenchymal Stem Cells Market: Overall Company Footprint Analysis
3.4.1 Mesenchymal Stem Cells Market: Region Footprint
3.4.2 Mesenchymal Stem Cells Market: Company Product Type Footprint
3.4.3 Mesenchymal Stem Cells Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Mesenchymal Stem Cells Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Mesenchymal Stem Cells Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Mesenchymal Stem Cells Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Mesenchymal Stem Cells Consumption Value Comparison
4.2.1 United States VS China: Mesenchymal Stem Cells Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Mesenchymal Stem Cells Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Mesenchymal Stem Cells Companies and Market Share, 2021-2026
4.3.1 United States Based Mesenchymal Stem Cells Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Mesenchymal Stem Cells Revenue, (2021-2026)
4.4 China Based Companies Mesenchymal Stem Cells Revenue and Market Share, 2021-2026
4.4.1 China Based Mesenchymal Stem Cells Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Mesenchymal Stem Cells Revenue, (2021-2026)
4.5 Rest of World Based Mesenchymal Stem Cells Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Mesenchymal Stem Cells Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Mesenchymal Stem Cells Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Mesenchymal Stem Cells Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Umbilical Cord Derived MSC
5.2.2 Bone Marrow Derived MSC
5.2.3 Placenta Derived MSC
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Mesenchymal Stem Cells Market Size by Type (2021-2026)
5.3.2 World Mesenchymal Stem Cells Market Size by Type (2027-2032)
5.3.3 World Mesenchymal Stem Cells Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Mesenchymal Stem Cells Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Research
6.2.2 Disease Treatment
6.2.3 Beauty and Anti-aging
6.2.4 Storage
6.3 Market Segment by Application
6.3.1 World Mesenchymal Stem Cells Market Size by Application (2021-2026)
6.3.2 World Mesenchymal Stem Cells Market Size by Application (2027-2032)
6.3.3 World Mesenchymal Stem Cells Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 CellResearch
7.1.1 CellResearch Details
7.1.2 CellResearch Major Business
7.1.3 CellResearch Mesenchymal Stem Cells Product and Services
7.1.4 CellResearch Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 CellResearch Recent Developments/Updates
7.1.6 CellResearch Competitive Strengths & Weaknesses
7.2 StemCord
7.2.1 StemCord Details
7.2.2 StemCord Major Business
7.2.3 StemCord Mesenchymal Stem Cells Product and Services
7.2.4 StemCord Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 StemCord Recent Developments/Updates
7.2.6 StemCord Competitive Strengths & Weaknesses
7.3 Cytopeutics
7.3.1 Cytopeutics Details
7.3.2 Cytopeutics Major Business
7.3.3 Cytopeutics Mesenchymal Stem Cells Product and Services
7.3.4 Cytopeutics Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Cytopeutics Recent Developments/Updates
7.3.6 Cytopeutics Competitive Strengths & Weaknesses
7.4 CryoCord
7.4.1 CryoCord Details
7.4.2 CryoCord Major Business
7.4.3 CryoCord Mesenchymal Stem Cells Product and Services
7.4.4 CryoCord Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 CryoCord Recent Developments/Updates
7.4.6 CryoCord Competitive Strengths & Weaknesses
7.5 Cell Malaysia
7.5.1 Cell Malaysia Details
7.5.2 Cell Malaysia Major Business
7.5.3 Cell Malaysia Mesenchymal Stem Cells Product and Services
7.5.4 Cell Malaysia Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Cell Malaysia Recent Developments/Updates
7.5.6 Cell Malaysia Competitive Strengths & Weaknesses
7.6 Bangkok Stem Cell
7.6.1 Bangkok Stem Cell Details
7.6.2 Bangkok Stem Cell Major Business
7.6.3 Bangkok Stem Cell Mesenchymal Stem Cells Product and Services
7.6.4 Bangkok Stem Cell Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Bangkok Stem Cell Recent Developments/Updates
7.6.6 Bangkok Stem Cell Competitive Strengths & Weaknesses
7.7 Vinmec Stem Cell Institute
7.7.1 Vinmec Stem Cell Institute Details
7.7.2 Vinmec Stem Cell Institute Major Business
7.7.3 Vinmec Stem Cell Institute Mesenchymal Stem Cells Product and Services
7.7.4 Vinmec Stem Cell Institute Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Vinmec Stem Cell Institute Recent Developments/Updates
7.7.6 Vinmec Stem Cell Institute Competitive Strengths & Weaknesses
7.8 ProSTEM
7.8.1 ProSTEM Details
7.8.2 ProSTEM Major Business
7.8.3 ProSTEM Mesenchymal Stem Cells Product and Services
7.8.4 ProSTEM Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 ProSTEM Recent Developments/Updates
7.8.6 ProSTEM Competitive Strengths & Weaknesses
7.9 Cryoviva
7.9.1 Cryoviva Details
7.9.2 Cryoviva Major Business
7.9.3 Cryoviva Mesenchymal Stem Cells Product and Services
7.9.4 Cryoviva Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Cryoviva Recent Developments/Updates
7.9.6 Cryoviva Competitive Strengths & Weaknesses
7.10 StemCells21
7.10.1 StemCells21 Details
7.10.2 StemCells21 Major Business
7.10.3 StemCells21 Mesenchymal Stem Cells Product and Services
7.10.4 StemCells21 Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 StemCells21 Recent Developments/Updates
7.10.6 StemCells21 Competitive Strengths & Weaknesses
7.11 Lonza
7.11.1 Lonza Details
7.11.2 Lonza Major Business
7.11.3 Lonza Mesenchymal Stem Cells Product and Services
7.11.4 Lonza Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Lonza Recent Developments/Updates
7.11.6 Lonza Competitive Strengths & Weaknesses
7.12 Thermo Fisher Scientific
7.12.1 Thermo Fisher Scientific Details
7.12.2 Thermo Fisher Scientific Major Business
7.12.3 Thermo Fisher Scientific Mesenchymal Stem Cells Product and Services
7.12.4 Thermo Fisher Scientific Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 Thermo Fisher Scientific Recent Developments/Updates
7.12.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.13 PromoCell
7.13.1 PromoCell Details
7.13.2 PromoCell Major Business
7.13.3 PromoCell Mesenchymal Stem Cells Product and Services
7.13.4 PromoCell Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 PromoCell Recent Developments/Updates
7.13.6 PromoCell Competitive Strengths & Weaknesses
7.14 Stemcell Technologies
7.14.1 Stemcell Technologies Details
7.14.2 Stemcell Technologies Major Business
7.14.3 Stemcell Technologies Mesenchymal Stem Cells Product and Services
7.14.4 Stemcell Technologies Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 Stemcell Technologies Recent Developments/Updates
7.14.6 Stemcell Technologies Competitive Strengths & Weaknesses
7.15 Bio-Techne
7.15.1 Bio-Techne Details
7.15.2 Bio-Techne Major Business
7.15.3 Bio-Techne Mesenchymal Stem Cells Product and Services
7.15.4 Bio-Techne Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.15.5 Bio-Techne Recent Developments/Updates
7.15.6 Bio-Techne Competitive Strengths & Weaknesses
7.16 ATCC
7.16.1 ATCC Details
7.16.2 ATCC Major Business
7.16.3 ATCC Mesenchymal Stem Cells Product and Services
7.16.4 ATCC Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.16.5 ATCC Recent Developments/Updates
7.16.6 ATCC Competitive Strengths & Weaknesses
7.17 Merck
7.17.1 Merck Details
7.17.2 Merck Major Business
7.17.3 Merck Mesenchymal Stem Cells Product and Services
7.17.4 Merck Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026)
7.17.5 Merck Recent Developments/Updates
7.17.6 Merck Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Mesenchymal Stem Cells Industry Chain
8.2 Mesenchymal Stem Cells Upstream Analysis
8.3 Mesenchymal Stem Cells Midstream Analysis
8.4 Mesenchymal Stem Cells Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Mesenchymal Stem Cells Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Mesenchymal Stem Cells Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Mesenchymal Stem Cells Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Mesenchymal Stem Cells Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Mesenchymal Stem Cells Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Mesenchymal Stem Cells Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Mesenchymal Stem Cells Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Mesenchymal Stem Cells Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Mesenchymal Stem Cells Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Mesenchymal Stem Cells Players in 2025
Table 12. World Mesenchymal Stem Cells Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Mesenchymal Stem Cells Company Evaluation Quadrant
Table 14. Head Office of Key Mesenchymal Stem Cells Players
Table 15. Mesenchymal Stem Cells Market: Company Product Type Footprint
Table 16. Mesenchymal Stem Cells Market: Company Product Application Footprint
Table 17. Mesenchymal Stem Cells Mergers & Acquisitions Activity
Table 18. United States VS China Mesenchymal Stem Cells Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Mesenchymal Stem Cells Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Mesenchymal Stem Cells Companies, Headquarters (States, Country)
Table 21. United States Based Companies Mesenchymal Stem Cells Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Mesenchymal Stem Cells Revenue Market Share (2021-2026)
Table 23. China Based Mesenchymal Stem Cells Companies, Headquarters (Province, Country)
Table 24. China Based Companies Mesenchymal Stem Cells Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Mesenchymal Stem Cells Revenue Market Share (2021-2026)
Table 26. Rest of World Based Mesenchymal Stem Cells Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Mesenchymal Stem Cells Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Mesenchymal Stem Cells Revenue Market Share (2021-2026)
Table 29. World Mesenchymal Stem Cells Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Mesenchymal Stem Cells Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Mesenchymal Stem Cells Market Size by Type (2027-2032) & (USD Million)
Table 32. World Mesenchymal Stem Cells Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Mesenchymal Stem Cells Market Size by Application (2021-2026) & (USD Million)
Table 34. World Mesenchymal Stem Cells Market Size by Application (2027-2032) & (USD Million)
Table 35. CellResearch Basic Information, Manufacturing Base and Competitors
Table 36. CellResearch Major Business
Table 37. CellResearch Mesenchymal Stem Cells Product and Services
Table 38. CellResearch Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. CellResearch Recent Developments/Updates
Table 40. CellResearch Competitive Strengths & Weaknesses
Table 41. StemCord Basic Information, Manufacturing Base and Competitors
Table 42. StemCord Major Business
Table 43. StemCord Mesenchymal Stem Cells Product and Services
Table 44. StemCord Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. StemCord Recent Developments/Updates
Table 46. StemCord Competitive Strengths & Weaknesses
Table 47. Cytopeutics Basic Information, Manufacturing Base and Competitors
Table 48. Cytopeutics Major Business
Table 49. Cytopeutics Mesenchymal Stem Cells Product and Services
Table 50. Cytopeutics Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Cytopeutics Recent Developments/Updates
Table 52. Cytopeutics Competitive Strengths & Weaknesses
Table 53. CryoCord Basic Information, Manufacturing Base and Competitors
Table 54. CryoCord Major Business
Table 55. CryoCord Mesenchymal Stem Cells Product and Services
Table 56. CryoCord Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. CryoCord Recent Developments/Updates
Table 58. CryoCord Competitive Strengths & Weaknesses
Table 59. Cell Malaysia Basic Information, Manufacturing Base and Competitors
Table 60. Cell Malaysia Major Business
Table 61. Cell Malaysia Mesenchymal Stem Cells Product and Services
Table 62. Cell Malaysia Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Cell Malaysia Recent Developments/Updates
Table 64. Cell Malaysia Competitive Strengths & Weaknesses
Table 65. Bangkok Stem Cell Basic Information, Manufacturing Base and Competitors
Table 66. Bangkok Stem Cell Major Business
Table 67. Bangkok Stem Cell Mesenchymal Stem Cells Product and Services
Table 68. Bangkok Stem Cell Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Bangkok Stem Cell Recent Developments/Updates
Table 70. Bangkok Stem Cell Competitive Strengths & Weaknesses
Table 71. Vinmec Stem Cell Institute Basic Information, Manufacturing Base and Competitors
Table 72. Vinmec Stem Cell Institute Major Business
Table 73. Vinmec Stem Cell Institute Mesenchymal Stem Cells Product and Services
Table 74. Vinmec Stem Cell Institute Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Vinmec Stem Cell Institute Recent Developments/Updates
Table 76. Vinmec Stem Cell Institute Competitive Strengths & Weaknesses
Table 77. ProSTEM Basic Information, Manufacturing Base and Competitors
Table 78. ProSTEM Major Business
Table 79. ProSTEM Mesenchymal Stem Cells Product and Services
Table 80. ProSTEM Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. ProSTEM Recent Developments/Updates
Table 82. ProSTEM Competitive Strengths & Weaknesses
Table 83. Cryoviva Basic Information, Manufacturing Base and Competitors
Table 84. Cryoviva Major Business
Table 85. Cryoviva Mesenchymal Stem Cells Product and Services
Table 86. Cryoviva Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Cryoviva Recent Developments/Updates
Table 88. Cryoviva Competitive Strengths & Weaknesses
Table 89. StemCells21 Basic Information, Manufacturing Base and Competitors
Table 90. StemCells21 Major Business
Table 91. StemCells21 Mesenchymal Stem Cells Product and Services
Table 92. StemCells21 Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. StemCells21 Recent Developments/Updates
Table 94. StemCells21 Competitive Strengths & Weaknesses
Table 95. Lonza Basic Information, Manufacturing Base and Competitors
Table 96. Lonza Major Business
Table 97. Lonza Mesenchymal Stem Cells Product and Services
Table 98. Lonza Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Lonza Recent Developments/Updates
Table 100. Lonza Competitive Strengths & Weaknesses
Table 101. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 102. Thermo Fisher Scientific Major Business
Table 103. Thermo Fisher Scientific Mesenchymal Stem Cells Product and Services
Table 104. Thermo Fisher Scientific Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Thermo Fisher Scientific Recent Developments/Updates
Table 106. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 107. PromoCell Basic Information, Manufacturing Base and Competitors
Table 108. PromoCell Major Business
Table 109. PromoCell Mesenchymal Stem Cells Product and Services
Table 110. PromoCell Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. PromoCell Recent Developments/Updates
Table 112. PromoCell Competitive Strengths & Weaknesses
Table 113. Stemcell Technologies Basic Information, Manufacturing Base and Competitors
Table 114. Stemcell Technologies Major Business
Table 115. Stemcell Technologies Mesenchymal Stem Cells Product and Services
Table 116. Stemcell Technologies Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Stemcell Technologies Recent Developments/Updates
Table 118. Stemcell Technologies Competitive Strengths & Weaknesses
Table 119. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 120. Bio-Techne Major Business
Table 121. Bio-Techne Mesenchymal Stem Cells Product and Services
Table 122. Bio-Techne Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Bio-Techne Recent Developments/Updates
Table 124. Bio-Techne Competitive Strengths & Weaknesses
Table 125. ATCC Basic Information, Manufacturing Base and Competitors
Table 126. ATCC Major Business
Table 127. ATCC Mesenchymal Stem Cells Product and Services
Table 128. ATCC Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. ATCC Recent Developments/Updates
Table 130. ATCC Competitive Strengths & Weaknesses
Table 131. Merck Basic Information, Manufacturing Base and Competitors
Table 132. Merck Major Business
Table 133. Merck Mesenchymal Stem Cells Product and Services
Table 134. Merck Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Merck Recent Developments/Updates
Table 136. Merck Competitive Strengths & Weaknesses
Table 137. Global Key Players of Mesenchymal Stem Cells Upstream (Raw Materials)
Table 138. Global Mesenchymal Stem Cells Typical Customers
Table 1. World Mesenchymal Stem Cells Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Mesenchymal Stem Cells Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Mesenchymal Stem Cells Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Mesenchymal Stem Cells Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Mesenchymal Stem Cells Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Mesenchymal Stem Cells Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Mesenchymal Stem Cells Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Mesenchymal Stem Cells Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Mesenchymal Stem Cells Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Mesenchymal Stem Cells Players in 2025
Table 12. World Mesenchymal Stem Cells Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Mesenchymal Stem Cells Company Evaluation Quadrant
Table 14. Head Office of Key Mesenchymal Stem Cells Players
Table 15. Mesenchymal Stem Cells Market: Company Product Type Footprint
Table 16. Mesenchymal Stem Cells Market: Company Product Application Footprint
Table 17. Mesenchymal Stem Cells Mergers & Acquisitions Activity
Table 18. United States VS China Mesenchymal Stem Cells Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Mesenchymal Stem Cells Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Mesenchymal Stem Cells Companies, Headquarters (States, Country)
Table 21. United States Based Companies Mesenchymal Stem Cells Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Mesenchymal Stem Cells Revenue Market Share (2021-2026)
Table 23. China Based Mesenchymal Stem Cells Companies, Headquarters (Province, Country)
Table 24. China Based Companies Mesenchymal Stem Cells Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Mesenchymal Stem Cells Revenue Market Share (2021-2026)
Table 26. Rest of World Based Mesenchymal Stem Cells Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Mesenchymal Stem Cells Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Mesenchymal Stem Cells Revenue Market Share (2021-2026)
Table 29. World Mesenchymal Stem Cells Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Mesenchymal Stem Cells Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Mesenchymal Stem Cells Market Size by Type (2027-2032) & (USD Million)
Table 32. World Mesenchymal Stem Cells Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Mesenchymal Stem Cells Market Size by Application (2021-2026) & (USD Million)
Table 34. World Mesenchymal Stem Cells Market Size by Application (2027-2032) & (USD Million)
Table 35. CellResearch Basic Information, Manufacturing Base and Competitors
Table 36. CellResearch Major Business
Table 37. CellResearch Mesenchymal Stem Cells Product and Services
Table 38. CellResearch Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. CellResearch Recent Developments/Updates
Table 40. CellResearch Competitive Strengths & Weaknesses
Table 41. StemCord Basic Information, Manufacturing Base and Competitors
Table 42. StemCord Major Business
Table 43. StemCord Mesenchymal Stem Cells Product and Services
Table 44. StemCord Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. StemCord Recent Developments/Updates
Table 46. StemCord Competitive Strengths & Weaknesses
Table 47. Cytopeutics Basic Information, Manufacturing Base and Competitors
Table 48. Cytopeutics Major Business
Table 49. Cytopeutics Mesenchymal Stem Cells Product and Services
Table 50. Cytopeutics Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Cytopeutics Recent Developments/Updates
Table 52. Cytopeutics Competitive Strengths & Weaknesses
Table 53. CryoCord Basic Information, Manufacturing Base and Competitors
Table 54. CryoCord Major Business
Table 55. CryoCord Mesenchymal Stem Cells Product and Services
Table 56. CryoCord Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. CryoCord Recent Developments/Updates
Table 58. CryoCord Competitive Strengths & Weaknesses
Table 59. Cell Malaysia Basic Information, Manufacturing Base and Competitors
Table 60. Cell Malaysia Major Business
Table 61. Cell Malaysia Mesenchymal Stem Cells Product and Services
Table 62. Cell Malaysia Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Cell Malaysia Recent Developments/Updates
Table 64. Cell Malaysia Competitive Strengths & Weaknesses
Table 65. Bangkok Stem Cell Basic Information, Manufacturing Base and Competitors
Table 66. Bangkok Stem Cell Major Business
Table 67. Bangkok Stem Cell Mesenchymal Stem Cells Product and Services
Table 68. Bangkok Stem Cell Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Bangkok Stem Cell Recent Developments/Updates
Table 70. Bangkok Stem Cell Competitive Strengths & Weaknesses
Table 71. Vinmec Stem Cell Institute Basic Information, Manufacturing Base and Competitors
Table 72. Vinmec Stem Cell Institute Major Business
Table 73. Vinmec Stem Cell Institute Mesenchymal Stem Cells Product and Services
Table 74. Vinmec Stem Cell Institute Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Vinmec Stem Cell Institute Recent Developments/Updates
Table 76. Vinmec Stem Cell Institute Competitive Strengths & Weaknesses
Table 77. ProSTEM Basic Information, Manufacturing Base and Competitors
Table 78. ProSTEM Major Business
Table 79. ProSTEM Mesenchymal Stem Cells Product and Services
Table 80. ProSTEM Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. ProSTEM Recent Developments/Updates
Table 82. ProSTEM Competitive Strengths & Weaknesses
Table 83. Cryoviva Basic Information, Manufacturing Base and Competitors
Table 84. Cryoviva Major Business
Table 85. Cryoviva Mesenchymal Stem Cells Product and Services
Table 86. Cryoviva Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Cryoviva Recent Developments/Updates
Table 88. Cryoviva Competitive Strengths & Weaknesses
Table 89. StemCells21 Basic Information, Manufacturing Base and Competitors
Table 90. StemCells21 Major Business
Table 91. StemCells21 Mesenchymal Stem Cells Product and Services
Table 92. StemCells21 Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. StemCells21 Recent Developments/Updates
Table 94. StemCells21 Competitive Strengths & Weaknesses
Table 95. Lonza Basic Information, Manufacturing Base and Competitors
Table 96. Lonza Major Business
Table 97. Lonza Mesenchymal Stem Cells Product and Services
Table 98. Lonza Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Lonza Recent Developments/Updates
Table 100. Lonza Competitive Strengths & Weaknesses
Table 101. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 102. Thermo Fisher Scientific Major Business
Table 103. Thermo Fisher Scientific Mesenchymal Stem Cells Product and Services
Table 104. Thermo Fisher Scientific Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Thermo Fisher Scientific Recent Developments/Updates
Table 106. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 107. PromoCell Basic Information, Manufacturing Base and Competitors
Table 108. PromoCell Major Business
Table 109. PromoCell Mesenchymal Stem Cells Product and Services
Table 110. PromoCell Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. PromoCell Recent Developments/Updates
Table 112. PromoCell Competitive Strengths & Weaknesses
Table 113. Stemcell Technologies Basic Information, Manufacturing Base and Competitors
Table 114. Stemcell Technologies Major Business
Table 115. Stemcell Technologies Mesenchymal Stem Cells Product and Services
Table 116. Stemcell Technologies Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Stemcell Technologies Recent Developments/Updates
Table 118. Stemcell Technologies Competitive Strengths & Weaknesses
Table 119. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 120. Bio-Techne Major Business
Table 121. Bio-Techne Mesenchymal Stem Cells Product and Services
Table 122. Bio-Techne Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Bio-Techne Recent Developments/Updates
Table 124. Bio-Techne Competitive Strengths & Weaknesses
Table 125. ATCC Basic Information, Manufacturing Base and Competitors
Table 126. ATCC Major Business
Table 127. ATCC Mesenchymal Stem Cells Product and Services
Table 128. ATCC Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. ATCC Recent Developments/Updates
Table 130. ATCC Competitive Strengths & Weaknesses
Table 131. Merck Basic Information, Manufacturing Base and Competitors
Table 132. Merck Major Business
Table 133. Merck Mesenchymal Stem Cells Product and Services
Table 134. Merck Mesenchymal Stem Cells Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Merck Recent Developments/Updates
Table 136. Merck Competitive Strengths & Weaknesses
Table 137. Global Key Players of Mesenchymal Stem Cells Upstream (Raw Materials)
Table 138. Global Mesenchymal Stem Cells Typical Customers
LIST OF FIGURES
Figure 1. Mesenchymal Stem Cells Picture
Figure 2. World Mesenchymal Stem Cells Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Mesenchymal Stem Cells Total Revenue (2021-2032) & (USD Million)
Figure 4. World Mesenchymal Stem Cells Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Mesenchymal Stem Cells Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Mesenchymal Stem Cells Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Mesenchymal Stem Cells Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Mesenchymal Stem Cells Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Mesenchymal Stem Cells Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Mesenchymal Stem Cells Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Mesenchymal Stem Cells Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Mesenchymal Stem Cells Revenue (2021-2032) & (USD Million)
Figure 13. Mesenchymal Stem Cells Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Mesenchymal Stem Cells Consumption Value (2021-2032) & (USD Million)
Figure 16. World Mesenchymal Stem Cells Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Mesenchymal Stem Cells Consumption Value (2021-2032) & (USD Million)
Figure 18. China Mesenchymal Stem Cells Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Mesenchymal Stem Cells Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Mesenchymal Stem Cells Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Mesenchymal Stem Cells Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Mesenchymal Stem Cells Consumption Value (2021-2032) & (USD Million)
Figure 23. India Mesenchymal Stem Cells Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Mesenchymal Stem Cells by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Mesenchymal Stem Cells Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Mesenchymal Stem Cells Markets in 2025
Figure 27. United States VS China: Mesenchymal Stem Cells Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Mesenchymal Stem Cells Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Mesenchymal Stem Cells Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Mesenchymal Stem Cells Market Size Market Share by Type in 2025
Figure 31. Umbilical Cord Derived MSC
Figure 32. Bone Marrow Derived MSC
Figure 33. Placenta Derived MSC
Figure 34. Other
Figure 35. World Mesenchymal Stem Cells Market Size Market Share by Type (2021-2032)
Figure 36. World Mesenchymal Stem Cells Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 37. World Mesenchymal Stem Cells Market Size Market Share by Application in 2025
Figure 38. Research
Figure 39. Disease Treatment
Figure 40. Beauty and Anti-aging
Figure 41. Storage
Figure 42. World Mesenchymal Stem Cells Market Size Market Share by Application (2021-2032)
Figure 43. Mesenchymal Stem Cells Industrial Chain
Figure 44. Methodology
Figure 45. Research Process and Data Source
Figure 1. Mesenchymal Stem Cells Picture
Figure 2. World Mesenchymal Stem Cells Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Mesenchymal Stem Cells Total Revenue (2021-2032) & (USD Million)
Figure 4. World Mesenchymal Stem Cells Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Mesenchymal Stem Cells Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Mesenchymal Stem Cells Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Mesenchymal Stem Cells Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Mesenchymal Stem Cells Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Mesenchymal Stem Cells Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Mesenchymal Stem Cells Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Mesenchymal Stem Cells Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Mesenchymal Stem Cells Revenue (2021-2032) & (USD Million)
Figure 13. Mesenchymal Stem Cells Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Mesenchymal Stem Cells Consumption Value (2021-2032) & (USD Million)
Figure 16. World Mesenchymal Stem Cells Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Mesenchymal Stem Cells Consumption Value (2021-2032) & (USD Million)
Figure 18. China Mesenchymal Stem Cells Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Mesenchymal Stem Cells Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Mesenchymal Stem Cells Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Mesenchymal Stem Cells Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Mesenchymal Stem Cells Consumption Value (2021-2032) & (USD Million)
Figure 23. India Mesenchymal Stem Cells Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Mesenchymal Stem Cells by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Mesenchymal Stem Cells Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Mesenchymal Stem Cells Markets in 2025
Figure 27. United States VS China: Mesenchymal Stem Cells Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Mesenchymal Stem Cells Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Mesenchymal Stem Cells Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Mesenchymal Stem Cells Market Size Market Share by Type in 2025
Figure 31. Umbilical Cord Derived MSC
Figure 32. Bone Marrow Derived MSC
Figure 33. Placenta Derived MSC
Figure 34. Other
Figure 35. World Mesenchymal Stem Cells Market Size Market Share by Type (2021-2032)
Figure 36. World Mesenchymal Stem Cells Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 37. World Mesenchymal Stem Cells Market Size Market Share by Application in 2025
Figure 38. Research
Figure 39. Disease Treatment
Figure 40. Beauty and Anti-aging
Figure 41. Storage
Figure 42. World Mesenchymal Stem Cells Market Size Market Share by Application (2021-2032)
Figure 43. Mesenchymal Stem Cells Industrial Chain
Figure 44. Methodology
Figure 45. Research Process and Data Source
